爱尔眼科(300015)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

300015 爱尔眼科

交易中 01-12 14:37:54

{"stockData":{"symbol":"300015","market":"SZ","secType":"STK","nameCN":"爱尔眼科","latestPrice":11.61,"timestamp":1768199874000,"preClose":11.42,"halted":0,"volume":83233546,"delay":0,"changeRate":0.0166,"floatShares":7955000000,"shares":9325000000,"eps":0.3452,"marketStatus":"交易中","change":0.19,"latestTime":"01-12 14:37:54","open":11.41,"high":11.65,"low":11.4,"amount":963000000,"amplitude":0.0219,"askPrice":11.62,"askSize":2680,"bidPrice":11.61,"bidSize":3257,"shortable":0,"etf":0,"ttmEps":0.3452,"tradingStatus":2,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1768201200000},"marketStatusCode":2,"adr":0,"adjPreClose":11.42,"symbolType":"stock","openAndCloseTimeList":[[1768181400000,1768188600000],[1768194000000,1768201200000]],"highLimit":12.56,"lowLimit":10.28,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":9325396670,"isCdr":false,"pbRate":4.75,"roa":"--","peRate":33.632677,"roe":"14.32%","epsLYR":0.3847,"committee":-0.118137,"marketValue":108268000000,"turnoverRate":0.0105,"status":0,"floatMarketCap":92362000000},"requestUrl":"/m/hq/s/300015","defaultTab":"news","newsList":[{"id":"2602557933","title":"股市必读：1月9日爱尔眼科发生1笔大宗交易 成交金额249.95万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2602557933","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602557933?lang=zh_cn&edition=full","pubTime":"2026-01-12 02:27","pubTimestamp":1768156030,"startTime":"0","endTime":"0","summary":"截至2026年1月9日收盘，爱尔眼科报收于11.42元，上涨0.97%，换手率0.78%，成交量62.39万手，成交额7.11亿元。当日关注点来自交易信息汇总：1月9日主力资金净流入732.23万元，显示主力对爱尔眼科的短期关注度提升。来自交易信息汇总：同日游资资金净流出1358.58万元，表明游资在当日选择离场。来自交易信息汇总：散户资金净流入626.35万元，反映出散户投资者情绪偏积极。大宗交易1月9日爱尔眼科发生1笔大宗交易，成交金额249.95万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011200000982.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0113","BK0188","BK0012","BK0028","BK0096","LU1242518931.SGD","LU1146622755.USD","LU0979878070.USD","BK0114","BK0077","BK0196","BK0200","BK0236","300015","LU1242518857.USD","LU1820825898.SGD"],"gpt_icon":0},{"id":"2602197763","title":"公募“圈地”指数基金，“一指多发”仍是头部游戏","url":"https://stock-news.laohu8.com/highlight/detail?id=2602197763","media":"券商中国","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602197763?lang=zh_cn&edition=full","pubTime":"2026-01-09 07:20","pubTimestamp":1767914400,"startTime":"0","endTime":"0","summary":"炒股就看金麒麟分析师研报，权威，专业，及时，全面，助您挖掘潜力主题机会！　　持续落子之下，基金公司在指数基金上的“圈地”策略逐渐清晰。　　券商中国记者发现，在岁末年初的基金发行中，华泰柏瑞、汇添富、易方达等公募“一指多发”持续抢占市场份额。但这种长达数年乃至十年的策略布局，多见于头部公募，中小公募仍难以分到杯羹。　　即便是不发ETF的公募，中证A500布局同样“一指多发”。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/marketresearch/2026-01-09/doc-inhfsfzx6020676.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["159967","510300","600030","515890","000300.SH","512510","512880","399006","BK4550","399001","000688.SH","300015","CIIHY","510880","SINA","06806","BK4585","000905.SH","600621","BK4588","06030","000166"],"gpt_icon":0},{"id":"2602919863","title":"股市必读：爱尔眼科（300015）1月8日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2602919863","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602919863?lang=zh_cn&edition=full","pubTime":"2026-01-09 01:20","pubTimestamp":1767892819,"startTime":"0","endTime":"0","summary":"截至2026年1月8日收盘，爱尔眼科报收于11.31元，上涨0.44%，换手率0.63%，成交量50.11万手，成交额5.66亿元。董秘最新回复投资者： 贵公司开发的数字人运行的怎么样，大面积运用了吗？爱尔数字人“爱科” 已在部分大医院试运行，提供眼健康科普、医院信息咨询、诊疗及用药注意事项等功能，并持续升级逐步推广，助力眼科医院智能化。当日关注点来自交易信息汇总：1月8日主力资金净流出1659.82万元，散户资金净流入1318.68万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010900000925.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU1146622755.USD","BK0028","BK0200","LU1820825898.SGD","BK0114","BK0188","BK0196","BK0236","BK0077","LU1242518857.USD","BK0096","BK0012","BK0113","LU1242518931.SGD","LU0979878070.USD","300015"],"gpt_icon":0},{"id":"2601635478","title":"爱尔眼科：数字人“爱科”已在部分大医院试运行","url":"https://stock-news.laohu8.com/highlight/detail?id=2601635478","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601635478?lang=zh_cn&edition=full","pubTime":"2026-01-08 17:00","pubTimestamp":1767862839,"startTime":"0","endTime":"0","summary":"证券之星消息，爱尔眼科(300015)01月08日在投资者关系平台上答复投资者关心的问题。投资者提问：贵公司开发的数字人运行的怎么样，大面积运用了吗？爱尔眼科回复：谢谢您对公司的关注。爱尔数字人“爱科（Eyecho）” 已在部分大医院试运行，提供眼健康科普、医院信息咨询、诊疗及用药注意事项等功能，并持续升级逐步推广，助力眼科医院智能化。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010800026566.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU1146622755.USD","BK0028","BK0200","LU1820825898.SGD","BK0114","BK0188","BK0196","BK0236","BK0077","LU1242518857.USD","BK0096","BK0012","BK0113","LU1242518931.SGD","LU0979878070.USD","300015"],"gpt_icon":0},{"id":"2601766378","title":"爱尔眼科：小青葵系列产品已实现量产","url":"https://stock-news.laohu8.com/highlight/detail?id=2601766378","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601766378?lang=zh_cn&edition=full","pubTime":"2026-01-07 17:21","pubTimestamp":1767777668,"startTime":"0","endTime":"0","summary":"证券之星消息，爱尔眼科(300015)01月07日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘您好，公司自主研发的（小青葵）系列产品量产了吗？爱尔眼科回复：谢谢您对公司的关注。“小青葵”系列产品已实现量产，具有良好的近视防控效果。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010700026478.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0113","LU1242518931.SGD","BK0114","BK0236","BK0028","BK0196","LU1146622755.USD","BK0012","300015","LU0979878070.USD","LU1242518857.USD","LU1820825898.SGD","BK0200","BK0188","BK0077","BK0096"],"gpt_icon":0},{"id":"2601187268","title":"爱尔眼科（300015）披露2025年中期分红派息实施公告，1月6日股价上涨1.97%","url":"https://stock-news.laohu8.com/highlight/detail?id=2601187268","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601187268?lang=zh_cn&edition=full","pubTime":"2026-01-06 22:08","pubTimestamp":1767708507,"startTime":"0","endTime":"0","summary":"截至2026年1月6日收盘，爱尔眼科报收于11.4元，较前一交易日上涨1.97%，最新总市值为1063.1亿元。该股当日开盘11.19元，最高11.48元，最低11.19元，成交额达10.57亿元，换手率为1.17%。公司近日发布公告称，将实施2025年中期分红派息方案。本次分红以公司总股本9,325,396,670股扣除回购股份31,363,178股后的9,294,033,492股为基数，向全体股东每10股派0.8元现金（含税），共计派发743,522,679.36元。现金红利由中国证券登记结算有限责任公司深圳分公司代派，部分股东由公司自行派发。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010600042251.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU1242518931.SGD","BK0096","BK0012","BK0236","300015","LU0979878070.USD","LU1146622755.USD","BK0114","BK0188","LU1820825898.SGD","BK0200","LU1242518857.USD","BK0196","BK0028","BK0077","BK0113"],"gpt_icon":0},{"id":"2601898179","title":"爱尔眼科：子公司更名系为更好满足发展需要","url":"https://stock-news.laohu8.com/highlight/detail?id=2601898179","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601898179?lang=zh_cn&edition=full","pubTime":"2026-01-06 17:27","pubTimestamp":1767691634,"startTime":"0","endTime":"0","summary":"证券之星消息，爱尔眼科(300015)01月06日在投资者关系平台上答复投资者关心的问题。投资者提问：请问2023年为什么要将2022年合并而来的宜昌西陵爱尔眼科医院有限公司更名为宜昌爱尔东山眼科医院有限公司，且未在年报中做说明，并且同年新设同名子公司“宜昌西陵爱尔眼科医院有限公司”，导致“宜昌西陵爱尔”这一标识同时出现在新设主体与商誉披露中爱尔眼科回复：谢谢关注。子公司更名是为了更好地满足发展需要，相关操作及信息披露符合法规要求。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010600028916.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300015","BK0200","BK0113","BK0114","BK0188","LU0979878070.USD","BK0077","LU1146622755.USD","BK0028","BK0196","LU1242518857.USD","LU1242518931.SGD","BK0012","BK0236","BK0096","LU1820825898.SGD"],"gpt_icon":0},{"id":"2601001943","title":"爱尔眼科：向投资者赠送“明眸远观福利”","url":"https://stock-news.laohu8.com/highlight/detail?id=2601001943","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601001943?lang=zh_cn&edition=full","pubTime":"2026-01-05 16:42","pubTimestamp":1767602541,"startTime":"0","endTime":"0","summary":"证券之星消息，爱尔眼科(300015)01月05日在投资者关系平台上答复投资者关心的问题。投资者提问：请问股东在实物上会有什么福利吗，比如送点卖不掉的库存?或者参与新品推广，做手术打打折?爱尔眼科回复：谢谢您对公司的关注。公司在上市十五周年之际，向所有爱尔眼科投资者赠送“明眸远观福利”，此项活动长期有效，具体参与方式请参阅公司于2024年10月31日发布的《关于举办“上市十五年，回馈投资者”活动的公告 》。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010500021597.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300015","LU1146622755.USD","BK0096","BK0028","BK0113","BK0114","BK0188","BK0196","LU0979878070.USD","LU1242518931.SGD","BK0012","BK0236","LU1242518857.USD","LU1820825898.SGD","BK0200","BK0077"],"gpt_icon":0},{"id":"2601026949","title":"股市必读：爱尔眼科（300015）12月31日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2601026949","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601026949?lang=zh_cn&edition=full","pubTime":"2026-01-05 01:00","pubTimestamp":1767546043,"startTime":"0","endTime":"0","summary":"截至2025年12月31日收盘，爱尔眼科报收于10.98元，下跌0.45%，换手率0.44%，成交量35.18万手，成交额3.87亿元。董秘最新回复投资者： 贵公司股价从92.69元跌至今年最低9.05元，已连续5年下跌，获利盘只有4.05%。看公司公告，经常有闲置资金做理财，建议爱尔眼科回购注销股份，做好市值管理。现金分红既是公司积极响应政策的号召，更是公司对投资者真心实意的回报。当日关注点来自交易信息汇总：12月31日主力资金净流出5408.91万元，占总成交额13.99%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010500000316.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU1820825898.SGD","BK0096","BK0188","300015","LU0979878070.USD","BK0200","BK0028","LU1242518857.USD","BK0113","BK0196","LU1146622755.USD","LU1242518931.SGD","BK0236","BK0077","BK0114","BK0012"],"gpt_icon":0},{"id":"2595797883","title":"爱尔眼科：公司经营正常坚定推进“1+8+N”战略","url":"https://stock-news.laohu8.com/highlight/detail?id=2595797883","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595797883?lang=zh_cn&edition=full","pubTime":"2025-12-30 20:53","pubTimestamp":1767099198,"startTime":"0","endTime":"0","summary":"证券之星消息，爱尔眼科12月30日在投资者关系平台上答复投资者关心的问题。公司经营正常，坚定推进“1+8+N”战略，持续提升经营管理、科研临床、医疗技能、就诊服务等多维度能力，并基于各阶段的发展战略和广大股东的长远利益合理规划使用资金，以增加公司收益。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025123000040914.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0196","BK0113","BK0236","BK0028","LU1820825898.SGD","BK0200","BK0114","LU1146622755.USD","300015","BK0012","BK0096","LU0979878070.USD","BK0188","LU1242518857.USD","LU1242518931.SGD","BK0077"],"gpt_icon":0},{"id":"2595857657","title":"爱尔眼科：坚持长期主义为股东创造价值","url":"https://stock-news.laohu8.com/highlight/detail?id=2595857657","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595857657?lang=zh_cn&edition=full","pubTime":"2025-12-29 17:21","pubTimestamp":1767000074,"startTime":"0","endTime":"0","summary":"证券之星消息，爱尔眼科(300015)12月29日在投资者关系平台上答复投资者关心的问题。投资者提问：请问公司是如何响应国家保护中小投资者的号召的，公司的市值变化明显是在为公司做负面宣传，很多人都已经不愿选择爱尔了，失信于投资者就会有失信于患者的可能。爱尔眼科回复：谢谢您对公司的关注。公司坚持长期主义，为社会和股东持续创造价值，积极响应国家保护投资者、特别是中小投资者的合法权益，通过多种措施增强投资者的获得感，持续提振信心，相信未来市值会有合理体现。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122900022746.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0196","LU1242518857.USD","LU1146622755.USD","LU1820825898.SGD","LU0979878070.USD","BK0012","BK0188","BK0113","300015","BK0096","BK0114","BK0200","LU1242518931.SGD","BK0028","BK0236"],"gpt_icon":0},{"id":"2594429981","title":"爱尔眼科：公司高度重视市值管理","url":"https://stock-news.laohu8.com/highlight/detail?id=2594429981","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2594429981?lang=zh_cn&edition=full","pubTime":"2025-12-26 20:52","pubTimestamp":1766753524,"startTime":"0","endTime":"0","summary":"证券之星消息，爱尔眼科12月25日在投资者关系平台上答复投资者关心的问题。公司高度重视市值管理，践行长期主义，多次通过高管增持、股份回购等多种措施提振信心，并持续加大现金分红力度，上市以来累计现金分红及股份回购总额将达84.49亿元。后续如有进一步增持计划，公司将按照相关规定及时披露。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122600033299.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0012","LU0979878070.USD","BK0028","300015","BK0196","BK0200","LU1242518857.USD","LU1242518931.SGD","BK0188","BK0236","BK0113","BK0096","LU1820825898.SGD","LU1146622755.USD","BK0114"],"gpt_icon":0},{"id":"2594308662","title":"爱尔眼科9.63亿元收购39家机构部分股权，多个标的处在扭亏为盈拐点","url":"https://stock-news.laohu8.com/highlight/detail?id=2594308662","media":"视频滚动新闻","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2594308662?lang=zh_cn&edition=full","pubTime":"2025-12-25 22:37","pubTimestamp":1766673420,"startTime":"0","endTime":"0","summary":"12月24日，爱尔眼科公告将以自有资金9.63亿元收购亳州爱尔、连云港爱尔等39家机构部分股权，交易对手多为投资基金。39家标的2024年整体收入6.86亿元、净利润亏损5899.51万元，2025年1 - 9月整体收入5.88亿元、净利润2024.59万元，大多处扭亏拐点。虽部分医院亏损、净资产为负，但收购利于控制成本，未来盈利将提升。2025年前三季度，爱尔眼科营收174.84亿元、同比增7.25%，归母净利润31.15亿元、同比降9.76%。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/videoroll/2025-12-25/doc-inhcztfz8678388.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0188","BK0012","LU0979878070.USD","LU1820825898.SGD","BK0236","LU1242518857.USD","BK0196","BK0200","BK0114","LU1242518931.SGD","BK0077","BK0113","BK0028","LU1146622755.USD","300015","BK0096"],"gpt_icon":0},{"id":"2593247405","title":"爱尔眼科(300015.SZ)拟9.63亿元收购亳州爱尔、连云港爱尔等39家机构部分股权","url":"https://stock-news.laohu8.com/highlight/detail?id=2593247405","media":"智通财经","labels":["shareholding","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593247405?lang=zh_cn&edition=full","pubTime":"2025-12-24 20:38","pubTimestamp":1766579930,"startTime":"0","endTime":"0","summary":"智通财经APP讯，爱尔眼科(300015.SZ)发布公告，公司于2025年12月24日召开第七届董事会第二次会议，审议通过《关于收购亳州爱尔、连云港爱尔等39家机构部分股权的议案》，本次交易以自有资金支付，交易合计金额为9.63亿元。公司本次收购39家机构的部分股权，有利于尽快完善区域市场布局，形成规模效应，进一步深化在全国各地的“分级连锁”体系，巩固和提升公司的领先地位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1385632.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"爱尔眼科(300015.SZ)拟9.63亿元收购亳州爱尔、连云港爱尔等39家机构部分股权","news_tag":"shareholding,merge","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0270","BK0236","LU1242518857.USD","BK0196","BK0077","BK0114","300015","LU1146622755.USD","BK0000","BK0028","BK0012","BK0200","BK0188","BK0113","601008","BK0047","LU0979878070.USD","LU1242518931.SGD","BK0096","LU1820825898.SGD"],"gpt_icon":0},{"id":"2593905994","title":"爱尔眼科：公司每年末对商誉资产进行减值测试","url":"https://stock-news.laohu8.com/highlight/detail?id=2593905994","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593905994?lang=zh_cn&edition=full","pubTime":"2025-12-23 20:51","pubTimestamp":1766494276,"startTime":"0","endTime":"0","summary":"证券之星消息，爱尔眼科12月22日在投资者关系平台上答复投资者关心的问题。投资者提问：公司的净资产220亿左右，商誉87亿占公司净资产接近40%的幅度，属于危险区域范围内，如果单院利润下降或者总体大幅度下滑，请问该公司怎么应对潜在威胁？公司每年末都会按照相关准则对商誉资产进行谨慎的减值测试，存在减值迹象的计提减值准备。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122300037542.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU1820825898.SGD","BK0096","BK0188","300015","LU0979878070.USD","BK0200","BK0028","LU1242518857.USD","BK0113","BK0196","LU1146622755.USD","LU1242518931.SGD","BK0236","BK0077","BK0114","BK0012"],"gpt_icon":0},{"id":"2593640394","title":"吉林通报不合格医疗器械 大安爱尔眼科眼部热敷贴登榜","url":"https://stock-news.laohu8.com/highlight/detail?id=2593640394","media":"中金财经","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593640394?lang=zh_cn&edition=full","pubTime":"2025-12-23 14:57","pubTimestamp":1766473024,"startTime":"0","endTime":"0","summary":"中国经济网北京12月23日讯 吉林省药品监督管理局网站近期发布吉林省医疗器械质量公告 。为加强医疗器械质量监督管理，保障医疗器械产品使用安全有效，吉林省药品监督管理局在全省范围内组织开展质量抽查检验，现将本期不合格产品信息予以公告。药品监督管理部门已要求相关单位采取风险防控措施，对不合格产品依据相关法律法规进行查处。","market":"hk","thumbnail":" http://caiji.3g.cnfol.com/colect/202512/23/20251223711027.png","type":0,"news_type":0,"thumbnails":[" http://caiji.3g.cnfol.com/colect/202512/23/20251223711027.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20251223/31884513.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["LU1242518931.SGD","300015","LU0979878070.USD","BK1222","BK1100","LU1146622755.USD","LU1242518857.USD","BK0096","LU1820825898.SGD","BK0114","09997","BK0012","09996","BK0028","BK0077","BK1574","159883","BK0113","BK0196","BK0236","BK0200","BK0188","BK1583"],"gpt_icon":0},{"id":"2592264905","title":"爱尔眼科：公司高度重视市值管理","url":"https://stock-news.laohu8.com/highlight/detail?id=2592264905","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592264905?lang=zh_cn&edition=full","pubTime":"2025-12-18 20:51","pubTimestamp":1766062299,"startTime":"0","endTime":"0","summary":"证券之星消息，爱尔眼科(300015)12月17日在投资者关系平台上答复投资者关心的问题。投资者提问：请问下董秘  多年来股票资金持续流出，股价持续探底，是不是公司价值投资，医疗龙头的概念，市场和股民对公司认可已经大幅度降低，公司有做市值管理或者后续有回购股票注销计划吗？爱尔眼科回复：谢谢关注。公司高度重视市值管理，持续加强市场沟通，并通过股份回购、高管增持、现金分红等多种措施体现信心，后续如有进一步回购计划，将按照相关规定及时披露。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121800035375.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","300015","BK0114","BK0196","BK0236","LU1146622755.USD","BK0113","BK0012","BK0028","LU0979878070.USD","BK0200","LU1820825898.SGD","BK0188","BK0096","LU1242518931.SGD","LU1242518857.USD"],"gpt_icon":0},{"id":"2591198418","title":"爱尔眼科：通过股份回购增强投资者获得感","url":"https://stock-news.laohu8.com/highlight/detail?id=2591198418","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591198418?lang=zh_cn&edition=full","pubTime":"2025-12-16 20:51","pubTimestamp":1765889494,"startTime":"0","endTime":"0","summary":"证券之星消息，爱尔眼科(300015)12月15日在投资者关系平台上答复投资者关心的问题。投资者提问：每天都在跌，每天都在创新低，理由是什么？公司股票跟大盘背道而驰，照这样跌下去，股价下个月就剩个位数的了，公司每年赚那么多钱，这个时候不拿出一部分钱回购股票，实在是寒了几十万股东的心了爱尔眼科回复：谢谢关注。公司坚持长期主义，为社会和股东持续创造价值，并通过股份回购、高管增持、现金分红等多种措施增强投资者的获得感， 后续如有进一步回购计划，公司将按规定披露信息。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121600038076.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU1146622755.USD","BK0196","300015","BK0200","BK0012","BK0114","BK0188","BK0077","BK0236","BK0028","LU0979878070.USD","BK0113","LU1242518931.SGD","LU1820825898.SGD","BK0096","LU1242518857.USD"],"gpt_icon":0},{"id":"2591361405","title":"爱尔眼科：近视高发化、人口老龄化、生活手机化持续催生眼健康需求","url":"https://stock-news.laohu8.com/highlight/detail?id=2591361405","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591361405?lang=zh_cn&edition=full","pubTime":"2025-12-15 17:30","pubTimestamp":1765791040,"startTime":"0","endTime":"0","summary":"证券之星消息，爱尔眼科12月15日在投资者关系平台上答复投资者关心的问题。请问董秘，在公司股价不断创下上市新低，为何公司董事长和高层没有增持，公司高层是最了解公司生产经营情况及将来成长性的吧？近视高发化、人口老龄化、生活手机化都在持续催生眼健康需求，公司秉承长期主义，专注于高技术医疗、高标准服务、高质量发展。后续如有相关信息，公司将及时披露。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121500021645.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0012","BK0028","BK0188","LU0979878070.USD","BK0196","300015","BK0113","LU1820825898.SGD","BK0077","LU1242518857.USD","LU1146622755.USD","BK0236","LU1242518931.SGD","BK0096","BK0200","BK0114"],"gpt_icon":0},{"id":"2591660762","title":"爱尔眼科（300015）1889.05万股限售股将于12月15日解禁，占总股本0.2%","url":"https://stock-news.laohu8.com/highlight/detail?id=2591660762","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591660762?lang=zh_cn&edition=full","pubTime":"2025-12-15 08:02","pubTimestamp":1765756928,"startTime":"0","endTime":"0","summary":"证券之星消息，根据市场公开信息整理，爱尔眼科于12月15日将有1889.05万股限售股份解禁，为公司股权激励限售股份，占公司总股本0.2%。最近一年内，该股累计解禁2624.16万股，占总股本的0.28%。本次解禁后，公司还有13.7亿股限售股份，占总股本14.69%。爱尔眼科主营业务：主要从事各类眼科疾病诊疗、手术服务与医学验光配镜。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121500000294.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0012","LU1146622755.USD","LU1820825898.SGD","BK0077","BK0200","BK0028","BK0113","LU1242518857.USD","BK0114","LU0979878070.USD","LU1242518931.SGD","BK0188","BK0096","300015","BK0196","BK0236"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1768199878398,"stockEarnings":[{"period":"1week","weight":0.0401},{"period":"1month","weight":0.0169},{"period":"3month","weight":-0.0979},{"period":"6month","weight":-0.0871},{"period":"1year","weight":-0.0595},{"period":"ytd","weight":0.0401}],"compareEarnings":[{"period":"1week","weight":0.0382},{"period":"1month","weight":0.0564},{"period":"3month","weight":0.0573},{"period":"6month","weight":0.1739},{"period":"1year","weight":0.2831},{"period":"ytd","weight":0.0382}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"爱尔眼科医院集团股份有限公司","boardCode":"AI0083","boardName":"卫生","stockholders":"344788人(较上一季度增加0.27%)","perCapita":"23073股","listingDate":"2009-10-30","address":"湖南省长沙市天心区芙蓉南路一段188号爱尔大厦","registeredCapital":"932539万元","survey":"　　爱尔眼科医院集团股份有限公司的主营业务是各类眼科疾病诊疗、手术服务与医学验光配镜服务。公司的主要产品是屈光项目、白内障项目、眼前段项目、眼后段项目、视光服务项目。","listedPrice":28},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"爱尔眼科(300015)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供爱尔眼科(300015)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"爱尔眼科,300015,爱尔眼科股票,爱尔眼科股票老虎,爱尔眼科股票老虎国际,爱尔眼科行情,爱尔眼科股票行情,爱尔眼科股价,爱尔眼科股市,爱尔眼科股票价格,爱尔眼科股票交易,爱尔眼科股票购买,爱尔眼科股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"爱尔眼科(300015)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供爱尔眼科(300015)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}